4.7 Article

Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages

Journal

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 73, Issue 5, Pages 1314-1323

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/jac/dky014

Keywords

-

Funding

  1. UK Medical Research Council (MRC)
  2. UK Department for International Development (DFID) under the MRC/DFID [MR/J008702/1]
  3. United Kingdom Medical Research Council Fellowship [MR/M008665/1]
  4. Medical Research Council [MR/J008702/1, MR/M008665/1] Funding Source: researchfish
  5. MRC [MR/J008702/1, MR/M008665/1] Funding Source: UKRI

Ask authors/readers for more resources

Objectives: We examined the in vitro pharmacodynamics and cellular accumulation of the standard anti-leishmanial drugs amphotericin B and miltefosine in intracellular Leishmania donovani amastigote-macrophage drug assays. Methods: Primary mouse macrophages were infected with L. donovani amastigotes. In time-kill assays infected macrophages were exposed to at least six different concentrations of serially diluted drugs and the percentage of infected macrophages was determined after 6, 12, 24, 48, 72 and 120 h of exposure. Cellular drug accumulation was measured following exposure to highly effective drug concentrations for 1, 6, 24, 48 and 72 h. Data were analysed through a mathematical model, relating drug concentration to the percentage of infected cells over time. Host cell membrane damage was evaluated through measurement of lactate dehydrogenase release. The effect of varying the serum and albumin concentrations in medium on the cellular accumulation levels of miltefosine was measured. Results: Amphotericin B was more potent than miltefosine (EC50 values of 0.65 and 1.26 mu M, respectively) and displayed a wider therapeutic window in vitro. The kinetics of the cellular accumulation of amphotericin B was concentration- and formulation-dependent. At an extracellular concentration of 10 mu M miltefosine maximum cellular drug levels preceded maximum anti-leishmanial kill. Miltefosine induced membrane damage in a concentration-, time- and serum-dependent manner. Its cellular accumulation levels increased with decreasing amounts of protein in assay medium. Conclusions: We have developed a novel approach to investigate the cellular pharmacology of anti-leishmanial drugs that serves as a model for the characterization of new drug candidates.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

Late-onset neonatal sepsis: genetic differences by sex and involvement of the NOTCH pathway

Timothy H. Ciesielski, Xueyi Zhang, Alessandra Tacconelli, Irja Lutsar, Vincent Meiffredy de Cabre, Emmanuel Roilides, Cinzia Ciccacci, Paola Borgiani, William K. Scott, Scott M. Williams, Giorgio Sirugo

Summary: Late-onset neonatal sepsis (LOS) is a rare and severe condition with high mortality rates. This study aimed to identify genetic variants associated with LOS. The results showed that genetic susceptibility to LOS is sexually dimorphic and NOTCH signaling plays a role in determining risk. There were also sex-specific associations between genes and sepsis, highlighting the importance of sex-specific treatment strategies.

PEDIATRIC RESEARCH (2023)

Article Pharmacology & Pharmacy

Assessment of the nlmixr R package for population pharmacokinetic modeling: A metformin case study

Wen Yao Mak, Qing Xi Ooi, Cintia Valeria Cruz, Irene Looi, Kah Hay Yuen, Joseph F. Standing

Summary: This study utilized nlmixr to model the pharmacokinetic data of metformin and compared the performances of SAEM and FOCEi in terms of bias, precision, and robustness to initial estimates for parameter estimation. The results showed that SAEM outperformed FOCEi in these aspects.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Editorial Material Infectious Diseases

Learning and confirming in publicly funded antiviral trials

Joseph F. Standing, Akosua Adom Agyeman

LANCET INFECTIOUS DISEASES (2023)

Article Pediatrics

Optimising intravenous salbutamol in children: a phase 2 study

Sandra Walsh, Shan Pan, Yucheng Sheng, Frank Kloprogge, Joe F. Standing, Brian J. Anderson, Padmanabhan Ramnarayan

Summary: In this study, a PKPD model for salbutamol in pediatric patients was developed. The results showed that an infusion of 0.5 μg/kg/min after bolus achieves effective bronchodilation, but higher infusion rates are associated with increased tachycardia and hyperglycemia.

ARCHIVES OF DISEASE IN CHILDHOOD (2023)

Editorial Material Pharmacology & Pharmacy

Could Metabolomics Be the Key to Unlocking Precision Dosing in the Clinic?

Joseph F. Standing

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

Article Infectious Diseases

Applications of the hollow-fibre infection model (HFIM) in viral infection studies

Japhette E. Kembou-Ringert, John Readman, Claire M. Smith, Judith Breuer, Joseph F. Standing

Summary: Conventional cell culture systems involve growing cells in stationary cultures, which does not reflect normal physiological conditions. Hollow-fibre bioreactors have been developed to overcome these limitations and have been widely used in various fields. This review focuses on the usage of these bioreactors in viral infection studies and highlights their potential applications in vaccine development and antiviral resistance mechanisms.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Medicine, General & Internal

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher C. Butler, F. D. Richard Hobbs, Oghenekome A. Gbinigie, Najib M. Rahman, Gail Hayward, Duncan B. Richards, Jienchi Dorward, David M. Lowe, Joseph F. Standing, Judith Breuer, Saye Khoo, Stavros Petrou, Kerenza Hood, Jonathan S. Nguyen-Van-Tam, Mahendra G. Patel, Benjamin R. Saville, Joe Marion, Emma Ogburn, Julie Allen, Heather Rutter, Nick Francis, Nicholas P. B. Thomas, Philip Evans, Melissa Dobson, Tracie-Ann Madden, Jane Holmes, Victoria Harris, May Ee Png, Mark Lown, Oliver van Hecke, Michelle A. Detry, Christina T. Saunders, Mark Fitzgerald, Nicholas S. Berry, Lazaro Mwandigha, Ushma Galal, Sam Mort, Bhautesh D. Jani, Nigel D. Hart, Haroon Ahmed, Daniel Butler, Micheal McKenna, Jem Chalk, Layla Lavallee, Elizabeth Hadley, Lucy Cureton, Magdalena Benysek, Monique Andersson, Maria Coates, Sarah Barrett, Clare Bateman, Jennifer C. Davies, Ivy Raymundo-Wood, Andrew Ustianowski, Andrew Carson-Stevens, Ly-Mee Yu, Paul Little

Summary: This study aimed to determine the safety, effectiveness, and cost-effectiveness of molnupiravir in vaccinated high-risk patients in the community. The results showed that molnupiravir did not reduce hospital admissions or deaths associated with COVID-19 compared to usual care in this population.

LANCET (2023)

Article Medicine, General & Internal

Impact of Misdiagnosis in Case-Control Studies of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Joao Malato, Luis Graca, Nuno Sepulveda

Summary: Misdiagnosis of ME/CFS can be caused by different case definitions or failure to diagnose other diseases, leading to difficulties in reproducing research findings. Simulated data showed that studies with over 500 individuals per group have a minimum power of 80% to detect a genuine association. However, in studies where the potential causal factor is not perfectly determined, such as serological association studies, a minimum power of 80% can only be achieved with over 1000 individuals per group.

DIAGNOSTICS (2023)

Article Infectious Diseases

Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings

J. B. Readman, M. Acman, A. Hamawandi, Cheng-Hsun Chiu, M. Sharland, J. A. Lindsay, J. F. Standing

Summary: In neonatal ICUs, ubiquitous infection with ESBL-producing Enterobacteriaceae is a major concern due to increasing antibiotic resistance. Distinguishing between bacterial and viral sepsis often leads to empirical antibiotics being used, contributing to resistance. Through testing, it was found that combining cefotaxime or ampicillin with sulbactam and gentamicin effectively inhibits the growth of ESBL-producing isolates and clears the infection. This combination showed consistent bactericidal activity at clinically achievable concentrations.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Review Anesthesiology

Pharmacokinetic pharmacodynamic modeling of analgesics and sedatives in children

Maddlie Bardol, Shan Pan, Suellen M. Walker, Joseph F. Standing, Joy M. Dawes

Summary: Pharmacokinetic pharmacodynamic modeling is a valuable tool for understanding the relationship between drug concentration and effect, particularly in pediatric patients. It helps to identify variability among patients and adjust dosing for optimal pain management. Consideration of size and maturation is crucial in accurate modeling and determining optimal dose in different age groups. However, assessing analgesic and sedative effects in children can be challenging due to the multidimensional nature of pain and limitations of measurement tools.

PEDIATRIC ANESTHESIA (2023)

Editorial Material Medicine, General & Internal

Editorial: Current research on serological analyses of infectious diseases

Eric William Rogier, Emanuele Giorgi, Kevin Tetteh, Nuno Sepulveda

FRONTIERS IN MEDICINE (2023)

Article Veterinary Sciences

Epidemiologic Factors Supporting Triage of Infected Dog Patients Admitted to a Veterinary Hospital Biological Isolation and Containment Unit

Ines Cunha Machado, Telmo Nunes, Miguel Maximino, Joao Malato, Luis Tavares, Virgilio Almeida, Nuno Sepulveda, Solange Gil

Summary: By creating infectious disease surveillance systems, routine collection and analysis of clinical data can contribute to an epidemiologic control of infectious diseases. The Biological Isolation and Containment Unit of the Faculty of Veterinary Medicine, University of Lisbon, has a database for collecting data on pets with infectious diseases. This study aims to identify the main dog infectious diseases over a 7-year period and analyze potential risk factors. The most frequent diagnoses were parvovirosis, leptospirosis, multidrug-resistant bacterial infections, and distemper.

VETERINARY SCIENCES (2023)

Article Pharmacology & Pharmacy

Treosulfan Exposure Predicts Thalassemia-Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation

Aswin Anand Pai, Ezhilpavai Mohanan, John C. Panetta, Uday P. Kulkarni, Raveen Stephen Stallon Illangeswaran, Balaji Balakrishnan, Agila Jayaraman, Eunice S. Edison, Kavitha M. Lakshmi, Anup J. Devasia, Nambiathayil Aboobacker Fouzia, Anu Korula, Aby Abraham, Biju George, Alok Srivastava, Vikram Mathews, Joseph F. Standing, Poonkuzhali Balasubramanian

Summary: A new chemotherapy regimen has significantly improved hematopoietic stem cell transplantation outcomes for patients with high-risk beta-thalassemia major, but complications still exist. A study on the dose-exposure-response relationship of treosulfan reveals that lower exposure increases the risk of graft rejection and early transplant-related mortality. Therapeutic drug monitoring-based dose adjustment may be beneficial.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

Article Biochemistry & Molecular Biology

Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation

Anna D. Grabowska, Mateusz Watroba, Joanna Witkowska, Agnieszka Mikulska, Nuno Sepulveda, Dariusz Szukiewicz

Summary: The blood-brain barrier (BBB) plays a crucial role in regulating the flow of substances between the blood and the central nervous system. Disruption of the BBB due to imbalanced blood glucose levels can lead to neuroinflammation and increase the risk of neurodegenerative diseases. Resveratrol (RSV), a natural compound with anti-diabetic, anti-inflammatory, and neuroprotective properties, activates SIRT1, a key regulator of metabolism. This study aimed to assess the response of astrocyte SIRT1 to neuroinflammation and RSV treatment in different glycemic backgrounds. The results showed that abnormal glycemic states had a worse prognosis for RSV therapy effectiveness compared to normoglycemia.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Infectious Diseases

The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence

Charlotte I. S. Barker, Karin Kipper, Dagan O. Lonsdale, Kirstie Wright, Georgina Thompson, Min Kim, Mark A. Turner, Atholl Johnston, Mike Sharland, Joseph F. Standing, NAPPA Study Consortium

Summary: The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study aimed to characterize the pharmacokinetic profiles of commonly used penicillins in paediatric patients and provide evidence-based dosing recommendations for future use. The study analyzed data obtained during routine care and used model-based simulations to test dosing regimens.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

No Data Available